"After all patients complete their dosing protocol of the Phase 1b part of the study, the data will be analysed, a recommended Phase 2 dose chosen; we will report results to the market.“
They are getting prepped for Phase 2 with Her-vaxx so you would assume that the results have been positive thus far.They want to have all the data confirmed before presenting to the market which is fine.
They shouldn’t of told us that we could look forward to early data.
After good results it will all be forgotten.
Ann: Appendix 4C - quarterly, page-9
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
0.003(7.89%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 4.2¢ | 3.8¢ | $803.7K | 20.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 726658 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 3144925 | 22 |
View Market Depth
| Last trade - 12.39pm 04/12/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
